Market BuzZ

17/02/2021

The key to gaining a competitive advantage lies in having an in-depth understanding of the target audience, competitors, and the market. Market BuzZ, as part of market research services, strives to do the same, providing you with relevant information about market, industry trends, competitors' strategies, and innovations in the marketplace, among other things, thus helping you formulate effective marketing strategies, make informed decisions, and reach out to your prospective clients far and wide.

Right from employing industry-best practices and systematically gathering, recording, and analyzing data to helping you launch a new product / service, set prices, create a business plan, expand into new markets, etc., our experts can do it all. Our market research services encompass peer group development modeling and project evaluation, market assessment, benchmarking, data mining and segmentation, competitor analysis, industry trend forecasting, and a lot more.

06/02/2021

Real growth in UPI is now happening on the P2M side (good sign). P2P growth has plateaued. P2M now has 45% share in trasactions.
PhonePe continues to lead in January too with 41% market share
Paytm has been silently growing due to its better tech at the expense of GooglePay which is declining due to its transaction failure issues. Here is the MoM growth (Dec vs Jan)

PhonePe: 7.3%
GooglePay: -0.1%
Paytm: 29.69%

:Deepak Abbot

17/01/2021

Health workers torn between duty and safety, a long wait for the vaccines to come to market, little clarity around 'informed consent' for Covaxin-news relevant to India's fight against Covid-19

Health workers torn between duty and safety, a long wait for the vaccines to come to market, little clarity around 'informed consent' for Covaxin-news relevant to India's fight against Covid-19

25/06/2020

, which has got the DGCI's nod for the usage of the Drug in India, is all set to deliver 20,000 vials of the medicine for restricted emergency use in severe cases.

India has approved the generic versions made by Cipla and Hetero for restricted emergency use in severe Covid-19 cases.

20/06/2020

Glenmark pharmaceuticals on Saturday said it has launched Antiviral drug Favipiravir, under the brand FabiFlue , for the treatment of patients with mild to moderate COVID 19.
The Mumbai based firm had on Friday receive manufacturing and marketing approval from the drug controller general of India (DCGI).
FabiFlue is the first oral Favipiravir- approved medication for the treatment of COVID-19, the company said in statment.

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild

11/05/2020

Follow Us on Instagram!!

www.instagram.com/marketbuzz_ind

11/05/2020

According to a report by the Transparency Market Research, the global thin film drug manufacturing market is predicted to be worth US $15.9 billion by the end of 2024.

Read about how Indian companies are preparing: https://t.co/XitxZc6Tlh

15/08/2019

Wishing every Indian a Happy Independence Day. Let's work together towards progress of our country and create the India of our dreams. 🇮🇳

Jai Hind.

15/08/2019

A very happy Raksha Bandhan to all those who have amazing siblings beautiful relationship with them.

08/08/2019

e-Payment Solutions in India: Market Review 2018-2019 and Forecast to 2023 –

World's largest and most respected Market Research resource. Searchable database of market research reports incorporating all niche and top industries.

07/08/2019

No one said it would be easy to understand the wants and needs of 1.3 billion people in a country with 22 official languages. But that shouldn’t stop a brand with global ambitions from trying. Check out our 5 Rules of Conducting Market Research in India.

LRW offers five rules of engagement for any company or agency looking to develop a clearer picture of Indian consumers.

07/08/2019

According to the new market research report ‘Cold Chain Monitoring Market’, the monitoring market is expected to grow from USD 3.80 billion in 2018 to USD 6.46 billion by 2023 at a CAGR of 11.17 per cent between 2018 and 2023.

The growth of the cold chain monitoring market can be attributed to the increasing demand for temperature-sensitive drugs, rising demand for better food quality and need to reduce food wastage, growing demand for generic drugs owing to higher accessibility and growing governmental focus on issuing p...